Sunmax Biotechnology Co Stock Current Liabilities
| 4728 Stock | TWD 279.00 0.50 0.18% |
Sunmax Biotechnology Co fundamentals help investors to digest information that contributes to Sunmax Biotechnology's financial success or failures. It also enables traders to predict the movement of Sunmax Stock. The fundamental analysis module provides a way to measure Sunmax Biotechnology's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sunmax Biotechnology stock.
Sunmax |
Sunmax Biotechnology Co Company Current Liabilities Analysis
Sunmax Biotechnology's Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
| Competition |
In accordance with the recently published financial statements, Sunmax Biotechnology Co has a Current Liabilities of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The current liabilities for all Taiwan stocks is 100.0% higher than that of the company.
Did you try this?
Run Investing Opportunities Now
Investing OpportunitiesBuild portfolios using our predefined set of ideas and optimize them against your investing preferences |
| All Next | Launch Module |
Sunmax Fundamentals
| Return On Equity | 0.48 | |||
| Return On Asset | 0.28 | |||
| Profit Margin | 0.39 % | |||
| Operating Margin | 0.56 % | |||
| Current Valuation | 8.1 B | |||
| Shares Outstanding | 54.46 M | |||
| Shares Owned By Insiders | 41.47 % | |||
| Shares Owned By Institutions | 9.24 % | |||
| Price To Book | 7.26 X | |||
| Price To Sales | 5.86 X | |||
| Revenue | 1.04 B | |||
| Gross Profit | 894.45 M | |||
| EBITDA | 416.06 M | |||
| Net Income | 245.64 M | |||
| Book Value Per Share | 22.04 X | |||
| Cash Flow From Operations | 243.28 M | |||
| Earnings Per Share | 9.24 X | |||
| Number Of Employees | 22 | |||
| Beta | 0.31 | |||
| Market Capitalization | 7.19 B | |||
| Total Asset | 1.48 B | |||
| Annual Yield | 0.03 % | |||
| Net Asset | 1.48 B | |||
| Last Dividend Paid | 4.4 |
About Sunmax Biotechnology Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Sunmax Biotechnology Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sunmax Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sunmax Biotechnology Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Sunmax Biotechnology
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Sunmax Biotechnology position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunmax Biotechnology will appreciate offsetting losses from the drop in the long position's value.Moving against Sunmax Stock
The ability to find closely correlated positions to Sunmax Biotechnology could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Sunmax Biotechnology when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Sunmax Biotechnology - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Sunmax Biotechnology Co to buy it.
The correlation of Sunmax Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Sunmax Biotechnology moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Sunmax Biotechnology moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Sunmax Biotechnology can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Sunmax Stock Analysis
When running Sunmax Biotechnology's price analysis, check to measure Sunmax Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sunmax Biotechnology is operating at the current time. Most of Sunmax Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sunmax Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sunmax Biotechnology's price. Additionally, you may evaluate how the addition of Sunmax Biotechnology to your portfolios can decrease your overall portfolio volatility.